This episode of the Long COVID Clinical Podcast, hosted by Drs. Anita Chopra, Tiffany Walker, Andrew Schamess, and Aaron Friedberg, features Dr. Andrew Ayers, a specialist in allergy and immunology. The discussion focuses on the immunological processes involved in long COVID, including immune dysregulation, immune deficiency, and the role of mast cell activation syndrome (MCAS). Dr. Ayers explains the complexities of the immune system's response to long COVID, potential treatments like high-dose antihistamines and other therapies, and the impact of COVID and vaccinations on immune reactions. He also delves into patient phenotypes, drug allergies, and the gut microbiome's influence on immune responses. The episode concludes with a comprehensive review of MCAS management strategies and emphasizes the challenges faced by clinicians treating long COVID.

Edited and Produced by Christopher Chiu

In this episode of the Long COVID Clinical Podcast, we engage with Dr. Iman Majd, an expert in integrative medicine, to discuss the complexities of long COVID. They explore various symptoms, including fatigue and brain fog, and delve into integrative approaches that combine conventional and alternative treatments. Dr. Majd emphasizes the importance of personalized care, the role of supplements and herbal remedies, and the significance of an anti-inflammatory diet. The conversation highlights the need for patience and collaboration between patients and healthcare providers in the journey towards recovery from long COVID.

Edited and Produced by Christopher Chiu

In this episode of the Long COVID Clinical Podcast, Dr. Hector Bonilla discusses the similarities and differences between Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME-CFS). He shares insights from his clinical and research journey, emphasizing the importance of understanding the pathophysiology, diagnosis, and management strategies for these post-viral conditions. The conversation highlights the need for better research, patient advocacy, and the exploration of potential treatments such as low-dose naltrexone and Abilify. Dr. Bonilla stresses the significance of listening to patients and acknowledging their symptoms as real, while also addressing the gaps in current understanding and the urgency for more clinical trials.

Edited and Produced by Christopher Chiu